Characteristics of 145 chemotherapy arms in the 70 trials.

*In seven arms, cisplatin or carboplatin was investigated.‡New agent was defined as those including docetaxel, paclitaxel, vinorelbine, gemcitabine, and irinotecan (see Methods section).#Molecular-targeted agent was defined as agents acting on known specific molecular targets, such as tyrosine kinase inhibitors, neutralizing antibodies, and antisense oligonucleotides (see Methods section).* 在7个给药组中，对顺铂（cisplatin）与卡铂（carboplatin）予以研究。‡ 新型药物被定义为包含多西他赛（docetaxel）、紫杉醇（paclitaxel）、长春瑞滨（vinorelbine）、吉西他滨（gemcitabine）以及伊立替康（irinotecan）的药物（详见方法部分）。# 分子靶向药物（molecular-targeted agent）被定义为作用于已知特异性分子靶点的药物，例如酪氨酸激酶抑制剂（tyrosine kinase inhibitors）、中和抗体（neutralizing antibodies）以及反义寡核苷酸（antisense oligonucleotides）（详见方法部分）。